Difficulty: Medium
Average Score: 84%
Practice
Myelodysplastic syndromes are a group of clonal stem cell disorders. Which of the following type has the poorest prognosis according to the FAB system of classifications?
Correct answer
D
Rationale
In the FAB (French-American-British) classification system for myelodysplastic syndromes, the subtype with the poorest prognosis is "RA with excess blasts in transformation" (option D). This subtype represents a progression of disease characterized by the presence of a high percentage of blasts in the bone marrow, indicating a higher risk of transformation into acute myeloid leukemia.
Option A (Refractory anaemia) and Option B (RA with ring sideroblasts) are considered lower-risk subtypes in the FAB classification system. Refractory anaemia typically has a more indolent course with a lower risk of progression to acute leukemia. RA with ring sideroblasts is also associated with a better prognosis compared to RA with excess blasts.
Option C (RA with excess blasts) represents a higher-risk subtype than RA but is not as severe as RA with excess blasts in transformation. RA with excess blasts signifies a higher risk of progression to acute leukemia compared to RA alone but is not as advanced as the transformation stage.
Understanding the prognostic implications of different FAB classifications in myelodysplastic syndromes is crucial for guiding treatment decisions and predicting disease outcomes. It helps clinicians tailor management strategies based on the individual patient's risk profile, emphasizing the importance of accurate classification in optimizing patient care.
Option A (Refractory anaemia) and Option B (RA with ring sideroblasts) are considered lower-risk subtypes in the FAB classification system. Refractory anaemia typically has a more indolent course with a lower risk of progression to acute leukemia. RA with ring sideroblasts is also associated with a better prognosis compared to RA with excess blasts.
Option C (RA with excess blasts) represents a higher-risk subtype than RA but is not as severe as RA with excess blasts in transformation. RA with excess blasts signifies a higher risk of progression to acute leukemia compared to RA alone but is not as advanced as the transformation stage.
Understanding the prognostic implications of different FAB classifications in myelodysplastic syndromes is crucial for guiding treatment decisions and predicting disease outcomes. It helps clinicians tailor management strategies based on the individual patient's risk profile, emphasizing the importance of accurate classification in optimizing patient care.